Electrocardiography

Electrocardiograms (ECG) are a primary cardiac diagnostic test that measures the electrical activity in heart to identify overall cardiac function, arrhythmias and areas of ischemia and infarct. Standard 12-lead ECG breaks the 3D structure of the heart into 12 zones, each showing the electrical activity in that specific area of the heart. This narrows down areas where there are issues with coronary artery disease or electrophysiology issues. Many ambulatory heart monitors and consumer-grade ECG monitors use fewer leads so are less specific as to cardiac conditions or location of abnormal heart rhythms, but can show an issue that requires further diagnostic testing or treatment.

Midmark launches two ECG systems

Midmark Medical has launched two diagnostic devices, the IQflex ECG and IQclassic ECG, ambulatory care technologies that offer signal acquisition using Mortara Instruments' Veritas resting ECG interpretation algorithm.

Spacelabs releases two ECG devices

Spacelabs Healthcare has launched its CardioExpress SL12 and SL6 ECG devices to acquire 12-lead ECG data from cardiac patients.

AIM: Screening student athletes with ECG reduces costs, adds life years

Compared with no screening, screening young athletes with a 12-lead ECG, coupled with cardiovascular-focused history and physical exams, can significantly reduce costs and add years of life, according to a study published in the March 2 issue of the Annals of Internal Medicine.

CCI: Pre-hospital ECG significantly reduces door-to-balloon times

Individuals experiencing chest pain who had ECG assessments prior to arriving at the hospital experience a significantly reduced time-to-treatment or door-to-balloon time, based on a study in the January issue of Catheterization and Cardiovascular Interventions (CCI).

CardioComm begins shipping ECG management software

CardioComm Solutions has shipped its Global ECG Management System (GEMS) software as part of a multi-year North American licensing agreement with GE Healthcare, and a subsequent OEM agreement.

Zoll aligns with Inovise for ECG technology

Zoll Medical, a manufacturer of resuscitation devices and related software solutions, has entered into a multi-year agreement to license Inovise Medical's Audicor technology.

Report: Cost savings will drive ECG global market to nearly $160M by 2015

The global electrocardiography (ECG) market is expected to reach $157.9 million in 2015 with an annual growth rate of 3.7 percent, compared with a market valued at $122.2 million in 2008, according to estimates from market research firm GlobalData.

JAMA: Common ECG finding may indicate serious cardiac problems

A routine electrocardiogram (ECG) that signals a disorder of the electrical conducting system in one part of the heart previously believed to be benign is associated with an increased risk for atrial fibrillation, pacemaker implantation or death, according to a study in the June 24 issue of the Journal of the American Medical Association.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Trimed Popup
Trimed Popup